<img height="1" width="1" src="https://www.facebook.com/tr?id=914352225269004&amp;ev=PageView%20&amp;noscript=1">
evrilink login Contact us
View active trials

Dementia-related Agitation Study

This study aims to evaluate the effectiveness and safety of a potential new treatment for dementia-related agitation.

Eligibility
  • 50 - 90 years of age
  • Current diagnosis of dementia (Alzheimer’s disease, Frontotemporal dementia, Lewy body dementia, multi-infarct dementia or vascular dementia)
  • Experiencing agitation/aggression episodes at least twice per week
  • Live at home 
  • Have a caregiver or study partner who will be available to participate in the study

 

Location
  • VIC

Duration

  • Up to 10 weeks

Read more
Evrima - Dementia

Register your interest today.

Dementia encompasses a range of cognitive impairments including memory loss, language difficulties, and challenges with problem-solving, all of which significantly interfere with daily life. As the disease gets worse, people with dementia may become agitated and may be restless or worried. Agitation may cause pacing, sleeplessness, or aggression.

Contact Form
FAQS Evrima

Need help with clinical trial information?

Search our Evrima help Centre for answers related to information about our active studies, information about managing your Evrilink account, and general clinical trial knowledge!

Read our FAQs